Opioid withdrawal resident survival guide: Difference between revisions

Jump to navigation Jump to search
Line 40: Line 40:
Shown below is an algorithm depicting the management of opioid withdrawal based on hospital concepts.<ref name="Huitink-2003">{{Cite journal  | last1 = Huitink | first1 = J. | last2 = Buitelaar | first2 = D. | title = Management of drug and alcohol withdrawal. | journal = N Engl J Med | volume = 349 | issue = 4 | pages = 405-7; author reply 405-7 | month = Jul | year = 2003 | doi =  | PMID = 12879900 }}</ref>
Shown below is an algorithm depicting the management of opioid withdrawal based on hospital concepts.<ref name="Huitink-2003">{{Cite journal  | last1 = Huitink | first1 = J. | last2 = Buitelaar | first2 = D. | title = Management of drug and alcohol withdrawal. | journal = N Engl J Med | volume = 349 | issue = 4 | pages = 405-7; author reply 405-7 | month = Jul | year = 2003 | doi =  | PMID = 12879900 }}</ref>
{{familytree/start |summary=PE diagnosis Algorithm.}}
{{familytree/start |summary=PE diagnosis Algorithm.}}
{{familytree | | | | | | | | A01 |A01=<div style="float: left; text-align: left">'''Characterize the symptoms:''' <br>❑ Flu like illness <br>❑ Lacrimation<br>  ❑ Rhinorrhea <br>❑ Sneezing<br> ❑ Yawning <br> ❑ [[Anorexia]] <br> ❑ [[Nausea]]<br> ❑ Vomiting<br> ❑ Abdominal cramps<br> ❑ [[Diarrhea]]<br> ❑ [[Myalgia]]<br> ❑ [[Arthralgia]] </div>}}  
{{familytree | | | A01 |A01=<div style="float: left; text-align: left">'''Characterize the symptoms:''' <br>❑ Flu like illness <br>❑ Lacrimation<br>  ❑ Rhinorrhea <br>❑ Sneezing<br> ❑ Yawning <br> ❑ [[Anorexia]] <br> ❑ [[Nausea]]<br> ❑ Vomiting<br> ❑ Abdominal cramps<br> ❑ [[Diarrhea]]<br> ❑ [[Myalgia]]<br> ❑ [[Arthralgia]] </div>}}  
{{familytree | | | | | | | | |!| | | | | | | | }}
{{familytree | | | |!| | | | | | | | }}
{{familytree | | | | | | | | B01 | | | | | | | |B01=<div style="float: left; text-align: left">'''Examine the patient:''' <br> ❑ Increase or unchanged [[blood pressure]]<br> ❑ Increase or unchanged [[heart rate]]<br> ❑ Increase or unchanged [[respiratory rate]]<br> ❑ [[Mydriasis]] <br> ❑ Piloerection <br> ❑ [[Tremor]]  <br> ❑ Increased bowel sounds </div> }}
{{familytree | | | B01 | | | | | | | |B01=<div style="float: left; text-align: left">'''Examine the patient:''' <br> ❑ Increase or unchanged [[blood pressure]]<br> ❑ Increase or unchanged [[heart rate]]<br> ❑ Increase or unchanged [[respiratory rate]]<br> ❑ [[Mydriasis]] <br> ❑ Piloerection <br> ❑ [[Tremor]]  <br> ❑ Increased bowel sounds </div> }}
{{familytree | | | | | | | | |!| | | | | | | | | | | }}
{{familytree | | | |!| | | | | | | | | | | }}
{{familytree | | | | | | | | X01 | | | | | | | | | |X01=<div style="float: left; text-align: left">'''Consider alternative diagnosis:''' <br> ❑ Alcohol withdrawal <br> ❑ [[Sedative-hypnotic|Sedative hypnotic withdrawal]] <br> ❑ [[Cholinergic|Cholinergic poisoning]] <br> ❑ [[Sympathomimetic|Sympathomimetic intoxication]] </div>}}
{{familytree | | | X01 | | | | | | | | | |X01=<div style="float: left; text-align: left">'''Consider alternative diagnosis:''' <br> ❑ Alcohol withdrawal <br> ❑ [[Sedative-hypnotic|Sedative hypnotic withdrawal]] <br> ❑ [[Cholinergic|Cholinergic poisoning]] <br> ❑ [[Sympathomimetic|Sympathomimetic intoxication]] </div>}}
{{familytree | | | | | | | | |!| | | | | | | | | | | }}
{{familytree | | | |!| | | | | | | | | | | }}
{{familytree | | | | | | | | C01 | | | | | | | | | |C01=Admit the patient }}
{{familytree | | | C01 | | | | | | | | | |C01=Admit the patient }}
{{familytree | | | | | | | | |!| | | | | | | | | | | }}
{{familytree | | | |!| | | | | | | | | | | }}
{{familytree | | | | | | | | D01 | | | | | | | | | |D01=<div style="float: left; text-align: left">Start opioid agonists:<ref name="Huitink-2003">{{Cite journal  | last1 = Huitink | first1 = J. | last2 = Buitelaar | first2 = D. | title = Management of drug and alcohol withdrawal. | journal = N Engl J Med | volume = 349 | issue = 4 | pages = 405-7; author reply 405-7 | month = Jul | year = 2003 | doi =  | PMID = 12879900 }}</ref><br> ❑ Methadone (pure agonist) 20-35 mg daily<br>
{{familytree | | | D01 | | | | | | | | | |D01=<div style="float: left; text-align: left">Start opioid agonists:<ref name="Huitink-2003">{{Cite journal  | last1 = Huitink | first1 = J. | last2 = Buitelaar | first2 = D. | title = Management of drug and alcohol withdrawal. | journal = N Engl J Med | volume = 349 | issue = 4 | pages = 405-7; author reply 405-7 | month = Jul | year = 2003 | doi =  | PMID = 12879900 }}</ref><br> ❑ Methadone (pure agonist) 20-35 mg daily<br>
'''or'''<br>
'''or'''<br>
❑ Buprenorphine (partial agonist) 4-16 mg sublingual daily  <br> ❑ Taper by 3% daily over next several days
❑ Buprenorphine (partial agonist) 4-16 mg sublingual daily  <br> ❑ Taper by 3% daily over next several days
Line 63: Line 63:
❑ Consult psychiatry
❑ Consult psychiatry
</div> }}
</div> }}
{{familytree | | | | | | | | |!| | | | | | | | | | | }}
{{familytree | | | |!| | | | | | | | | | | }}
{{familytree | | | | | | | | E01 | | | | | | | | | |E01=Detoxification<ref name="Huitink-2003">{{Cite journal  | last1 = Huitink | first1 = J. | last2 = Buitelaar | first2 = D. | title = Management of drug and alcohol withdrawal. | journal = N Engl J Med | volume = 349 | issue = 4 | pages = 405-7; author reply 405-7 | month = Jul | year = 2003 | doi =  | PMID = 12879900 }}</ref> }}
{{familytree | | | E01 | | | | | | | | | |E01=Detoxification<ref name="Huitink-2003">{{Cite journal  | last1 = Huitink | first1 = J. | last2 = Buitelaar | first2 = D. | title = Management of drug and alcohol withdrawal. | journal = N Engl J Med | volume = 349 | issue = 4 | pages = 405-7; author reply 405-7 | month = Jul | year = 2003 | doi =  | PMID = 12879900 }}</ref> }}
{{familytree | | | | |,|-|-|-|^|-|-|-|.| | | | | | | }}
{{familytree | |,|-|^|-|.| | | | | | | }}
{{familytree | | | | F01 | | | | | | F02 | | | | | |F01=<div style="float: left; text-align: left">'''Rapid detoxification:'''<ref name="O'Connor-1997">{{Cite journal  | last1 = O'Connor | first1 = PG. | last2 = Carroll | first2 = KM. | last3 = Shi | first3 = JM. | last4 = Schottenfeld | first4 = RS. | last5 = Kosten | first5 = TR. | last6 = Rounsaville | first6 = BJ. | title = Three methods of opioid detoxification in a primary care setting. A randomized trial. | journal = Ann Intern Med | volume = 127 | issue = 7 | pages = 526-30 | month = Oct | year = 1997 | doi =  | PMID = 9313020 }}</ref><br> For a patient receiving about 8 mg of buprenorphine or 35 mg of methadone<br>❑ Detoxify while awake or under mild sedation <br> ❑ Add [[naltrexone]]<br>
{{familytree | F01 | | F02 | | | | | |F01=<div style="float: left; text-align: left">'''Rapid detoxification:'''<ref name="O'Connor-1997">{{Cite journal  | last1 = O'Connor | first1 = PG. | last2 = Carroll | first2 = KM. | last3 = Shi | first3 = JM. | last4 = Schottenfeld | first4 = RS. | last5 = Kosten | first5 = TR. | last6 = Rounsaville | first6 = BJ. | title = Three methods of opioid detoxification in a primary care setting. A randomized trial. | journal = Ann Intern Med | volume = 127 | issue = 7 | pages = 526-30 | month = Oct | year = 1997 | doi =  | PMID = 9313020 }}</ref><br> For a patient receiving about 8 mg of buprenorphine or 35 mg of methadone<br>❑ Detoxify while awake or under mild sedation <br> ❑ Add [[naltrexone]]<br>
:❑ Day 1: 25 mg
:❑ Day 1: 25 mg
:❑ Days 2 to 15: 50 mg<br>
:❑ Days 2 to 15: 50 mg<br>
❑ Add clonidine 0.1-0.2 mg four times daily, tapered on days 2 and 3<br>
❑ Add clonidine 0.1-0.2 mg four times daily, tapered on days 2 and 3<br>
❑ Antiemetic agents as needed<br>❑ Analgesics as needed</div> |F02=<div style="float: left; text-align: left">'''Ultra rapid detoxification:'''<ref name="Presslich-1989">{{Cite journal  | last1 = Presslich | first1 = O. | last2 = Loimer | first2 = N. | last3 = Lenz | first3 = K. | last4 = Schmid | first4 = R. | title = Opiate detoxification under general anesthesia by large doses of naloxone. | journal = J Toxicol Clin Toxicol | volume = 27 | issue = 4-5 | pages = 263-70 | month =  | year = 1989 | doi =  | PMID = 2600989 }}</ref><ref name="Loimer-1991">{{Cite journal  | last1 = Loimer | first1 = N. | last2 = Lenz | first2 = K. | last3 = Schmid | first3 = R. | last4 = Presslich | first4 = O. | title = Technique for greatly shortening the transition from methadone to naltrexone maintenance of patients addicted to opiates. | journal = Am J Psychiatry | volume = 148 | issue = 7 | pages = 933-5 | month = Jul | year = 1991 | doi =  | PMID = 2053636 }}</ref><br>❑ Detoxify under heavy sedation or general anesthesia<br> ❑ Induce acute withdrawal with [[naloxone]]<br> ❑ Consider intubation and mechanical ventilation if necessary<br>❑ Antiemetic agents as needed<br>❑ Analgesics as needed </div> }}
❑ Antiemetic agents as needed<br>❑ Analgesics as needed</div> |F02=<div style="float: left; text-align: left">'''Ultra rapid detoxification:'''<ref name="Presslich-1989">{{Cite journal  | last1 = Presslich | first1 = O. | last2 = Loimer | first2 = N. | last3 = Lenz | first3 = K. | last4 = Schmid | first4 = R. | title = Opiate detoxification under general anesthesia by large doses of naloxone. | journal = J Toxicol Clin Toxicol | volume = 27 | issue = 4-5 | pages = 263-70 | month =  | year = 1989 | doi =  | PMID = 2600989 }}</ref><ref name="Loimer-1991">{{Cite journal  | last1 = Loimer | first1 = N. | last2 = Lenz | first2 = K. | last3 = Schmid | first3 = R. | last4 = Presslich | first4 = O. | title = Technique for greatly shortening the transition from methadone to naltrexone maintenance of patients addicted to opiates. | journal = Am J Psychiatry | volume = 148 | issue = 7 | pages = 933-5 | month = Jul | year = 1991 | doi =  | PMID = 2053636 }}</ref><br>❑ Detoxify under heavy sedation or general anesthesia<br> ❑ Induce acute withdrawal with [[naloxone]]<br> ❑ Consider intubation and mechanical ventilation if necessary<br>❑ Antiemetic agents as needed<br>❑ Analgesics as needed </div> }}
{{familytree | | | | | | | | | | | | | | | | | | | | }}
{{familytree | | | | | | | | | | | | | | | | | | | | }}
{{familytree | | | | | | | | | | | | | | | | | | | | }}
{{familytree/end}}
{{familytree/end}}



Revision as of 16:11, 31 January 2014

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vidit Bhargava, M.B.B.S [2]; Vendhan Ramanujam M.B.B.S [3]

Definition

Opioid withdrawal refers to the arrays of signs and symptoms following the abrupt cessation of opioids among chronic users.

Shown below is a table indicative of time to withdrawal symptoms for different opioids:[1][2]


Opioid Peak withdrawal symptoms Duration of symptoms
Heroin 36-72 hours 7-10 days
Methadone 72-96 hours 14 days or more
Buprenorphine 36-72 hours Intermediate between 7-14 days

Causes

Life Threatening Causes

Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated. Opioid withdrawal is a life-threatening condition and must be treated as such irrespective of the causes.

Common Causes

Management

Shown below is an algorithm depicting the management of opioid withdrawal based on hospital concepts.[3]

 
 
Characterize the symptoms:
❑ Flu like illness
❑ Lacrimation
❑ Rhinorrhea
❑ Sneezing
❑ Yawning
Anorexia
Nausea
❑ Vomiting
❑ Abdominal cramps
Diarrhea
Myalgia
Arthralgia
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Examine the patient:
❑ Increase or unchanged blood pressure
❑ Increase or unchanged heart rate
❑ Increase or unchanged respiratory rate
Mydriasis
❑ Piloerection
Tremor
❑ Increased bowel sounds
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Consider alternative diagnosis:
❑ Alcohol withdrawal
Sedative hypnotic withdrawal
Cholinergic poisoning
Sympathomimetic intoxication
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Admit the patient
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Start opioid agonists:[3]
❑ Methadone (pure agonist) 20-35 mg daily

or
❑ Buprenorphine (partial agonist) 4-16 mg sublingual daily
❑ Taper by 3% daily over next several days [4]


Add nonopioid drugs:
Clonidine 0.2 mg every 4 hours, tapered after day 3 [5]
or
Lofexidine 0.2 mg BD daily, titrated to 1.2 mg BD daily [6]
❑ Chlordiazepoxide as needed
❑ Treatment duration 10 days for heroin; 14 days for methadone


❑ General symptomatic management


❑ Consult psychiatry

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Detoxification[3]
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Rapid detoxification:[7]
For a patient receiving about 8 mg of buprenorphine or 35 mg of methadone
❑ Detoxify while awake or under mild sedation
❑ Add naltrexone
❑ Day 1: 25 mg
❑ Days 2 to 15: 50 mg

❑ Add clonidine 0.1-0.2 mg four times daily, tapered on days 2 and 3

❑ Antiemetic agents as needed
❑ Analgesics as needed
 
Ultra rapid detoxification:[8][9]
❑ Detoxify under heavy sedation or general anesthesia
❑ Induce acute withdrawal with naloxone
❑ Consider intubation and mechanical ventilation if necessary
❑ Antiemetic agents as needed
❑ Analgesics as needed
 
 
 
 
 

BID: Twice daily

Do's

  • Restrict methadone and other opioid agonists to inpatient settings or licensed programs.
  • Administer chlordiazepoxide, a longer-acting benzodiazepine to augument clonidine in patients with insomnia or muscle cramps.[5]
  • Detoxification should be undertaken only under clinicians with special training, equipment, or both.
  • Start buprenorphine at least two days before starting naltrexone during detoxification.

Dont's

  • Do not abruptly stop drugs that are being used to treat withdrawal.

References

  1. Jasinski, DR.; Pevnick, JS.; Griffith, JD. (1978). "Human pharmacology and abuse potential of the analgesic buprenorphine: a potential agent for treating narcotic addiction". Arch Gen Psychiatry. 35 (4): 501–16. PMID 215096. Unknown parameter |month= ignored (help)
  2. Opiods: detoxification. In: Galanter M, Kleber HD, eds. The American Psychiatric Press textbook of substance abuse treatment. 2nd ed. Washington, D.C.: American Psychiatric Press, 1999:251-69.>
  3. 3.0 3.1 3.2 Huitink, J.; Buitelaar, D. (2003). "Management of drug and alcohol withdrawal". N Engl J Med. 349 (4): 405–7, author reply 405-7. PMID 12879900. Unknown parameter |month= ignored (help)
  4. Senay, EC.; Dorus, W.; Goldberg, F.; Thornton, W. (1977). "Withdrawal from methadone maintenance. Rate of withdrawal and expectation". Arch Gen Psychiatry. 34 (3): 361–7. PMID 843188. Unknown parameter |month= ignored (help)
  5. 5.0 5.1 O'Connor, PG.; Waugh, ME.; Carroll, KM.; Rounsaville, BJ.; Diagkogiannis, IA.; Schottenfeld, RS. (1995). "Primary care-based ambulatory opioid detoxification: the results of a clinical trial". J Gen Intern Med. 10 (5): 255–60. PMID 7616334. Unknown parameter |month= ignored (help)
  6. Strang, J.; Bearn, J.; Gossop, M. (1999). "Lofexidine for opiate detoxification: review of recent randomised and open controlled trials". Am J Addict. 8 (4): 337–48. PMID 10598217.
  7. O'Connor, PG.; Carroll, KM.; Shi, JM.; Schottenfeld, RS.; Kosten, TR.; Rounsaville, BJ. (1997). "Three methods of opioid detoxification in a primary care setting. A randomized trial". Ann Intern Med. 127 (7): 526–30. PMID 9313020. Unknown parameter |month= ignored (help)
  8. Presslich, O.; Loimer, N.; Lenz, K.; Schmid, R. (1989). "Opiate detoxification under general anesthesia by large doses of naloxone". J Toxicol Clin Toxicol. 27 (4–5): 263–70. PMID 2600989.
  9. Loimer, N.; Lenz, K.; Schmid, R.; Presslich, O. (1991). "Technique for greatly shortening the transition from methadone to naltrexone maintenance of patients addicted to opiates". Am J Psychiatry. 148 (7): 933–5. PMID 2053636. Unknown parameter |month= ignored (help)


Template:WikiDoc Sources